ADMA Biologics Stock Target Price and Analyst Consensus

ADMA Stock  USD 6.60  0.14  2.08%   
The current analyst and expert consensus on ADMA Biologics is Strong Buy, with 3 strong buy opinions. The current projected ADMA Biologics target price consensus is 6.0 with 4 analyst opinions. The most common way ADMA Biologics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview ADMA Biologics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on ADMA Biologics. We encourage you to use your own analysis of ADMA Biologics to validate this buy or sell advice. ADMA Biologics buy-or-sell recommendation module provides average expert sentiment on the projected ADMA Biologics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on ADMA Biologics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
Lowest Forecast
5.46
Highest Forecast
6.66
Target Price
6
At present, ADMA Biologics' Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Operating Profit Margin is expected to grow to 0.09, whereas Pretax Profit Margin is forecasted to decline to (0.11). At present, ADMA Biologics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 148.5 M, whereas Cash is forecasted to decline to about 27.8 M.
  
It's important to approach ADMA Biologics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

ADMA Biologics Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ADMA target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ADMA Biologics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   4  Strong Buy
Most ADMA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ADMA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ADMA Biologics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

ADMA Biologics Target Price Projection

ADMA Biologics' current and average target prices are 6.60 and 6.00, respectively. The current price of ADMA Biologics is the price at which ADMA Biologics is currently trading. On the other hand, ADMA Biologics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

ADMA Biologics Market Quote on 29th of March 2024

Low Price6.51Odds
High Price6.76Odds

6.6

Target Price

Analyst Consensus On ADMA Biologics Target Price

Low Estimate5.46Odds
High Estimate6.66Odds

6.0

Historical Lowest Forecast  5.46 Target Price  6.0 Highest Forecast  6.66
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on ADMA Biologics and the information provided on this page.

ADMA Biologics Analyst Ratings

ADMA Biologics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about ADMA Biologics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of ADMA Biologics' financials, market performance, and future outlook by experienced professionals. ADMA Biologics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize ADMA Biologics price targets

ADMA Biologics' stock target price is an estimate of its future price, usually made by analysts. Using ADMA Biologics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at ADMA Biologics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if ADMA Biologics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional ADMA Biologics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of ADMA Biologics is a key component of ADMA Biologics valuation and have some predictive power on the future returns of a ADMA Biologics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ADMA Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
4.036.769.49
Details
Intrinsic
Valuation
LowRealHigh
3.886.619.34
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.050.050.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ADMA Biologics. Your research has to be compared to or analyzed against ADMA Biologics' peers to derive any actionable benefits. When done correctly, ADMA Biologics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ADMA Biologics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Cleaning Idea
Cleaning
Invested over 100 shares
Business Services Idea
Business Services
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 200 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:
Check out Macroaxis Advice on ADMA Biologics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for ADMA Stock analysis

When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
The data published in ADMA Biologics' official financial statements usually reflect ADMA Biologics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ADMA Biologics. For example, before you start analyzing numbers published by ADMA accountants, it's critical to develop an understanding of what ADMA Biologics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of ADMA Biologics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ADMA Biologics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ADMA Biologics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ADMA Biologics. Please utilize our Beneish M Score to check the likelihood of ADMA Biologics' management manipulating its earnings.